3 The pharmacokinetic feasibility gate: exposure, half-life, and the accumulation requirement The central determinant of whether an orally administered peptide achieves therapeutic systemic exposure is not the sophistication of the delivery platform, but the relationship among absorption rate, elimination half-life, and dosing interval
Read more about the Rybelsus vision loss MDL here
Patients often compare dose strength outcomes when reviewing effective dosing guidance, which explains how results relate to tolerance rather than speed
If you add too much or too little water, the primary risk is an accidental dosing error where you inject more or less medication than intended
Height was recorded in centimetres and body weight in kilograms, to one decimal place, while the participant was wearing light clothing and no shoes